Company intelligence / Profile preview

Impliant

Herzliya, Tel Aviv, Israelbiospace.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 2

Overview

Impliant developed the TOPS System, an innovative motion-preserving spinal implant designed to treat moderate to severe lumbar spinal stenosis and spondylolisthesis. The device aimed to provide stability while preserving range of motion at the affected vertebral segment. Clinical studies demonstrated improved outcomes over traditional fusion surgery for select patients. The company was acquired by Premia Spine, which continues development and commercialization of the technology.

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceImplant
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical partnerships reported; collaborations with leading orthopedic surgeons and clinical trial sites.

Beyond the preview

Go deeper on Impliant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impliant.

Explore the full profile